The effect of genistein on cisplatin induced ototoxicity and oxidative stress
Copyright © 2021 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier Editora Ltda. All rights reserved..
OBJECTIVE: Cisplatin is an antineoplastic agent used in adults and children for the treatment of various malignant diseases. It can cause irreversible ototoxicity. Genistein is a phytoestrogen. Genistein functions as an antioxidant and cell cycle inhibitor by inhibiting the DNA topoisomerase and tyrosine protein kinase enzymes. The protective effect of genistein in preventing cisplatin-induced ototoxicity and levels of the oxidative stress was investigated.
METHODS: 32 Sprague Dawley rats were used in 4 groups (control, cisplatin, cisplatin + genistein, genistein). Otoacoustic emission measurements of the distortion product were performed on the 1st, 2nd and 5th days of the test protocol. Serum malondialdehyde, superoxide dismutase, catalase, glutathione peroxidase, total antioxidant status, total oxidant status and oxidative stress index measurements were made.
RESULTS: The hearing of the cisplatin + genistein group was found to be better than that of the cisplatin group. While the malondialdehyde, total oxidant status and oxidative stress index parameters decreased significantly in the cisplatin + genistein group compared to the cisplatin group, superoxide dismutase increased significantly (p < 0.05).
CONCLUSION: Genistein showed positive effects against ototoxicity with its antioxidant effect.
LEVEL OF EVIDENCE: Level 3.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:88 |
|---|---|
| Enthalten in: |
Brazilian journal of otorhinolaryngology - 88(2022), 1 vom: 10. Jan., Seite 105-111 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tan, Mehmet [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antineoplastic Agents |
|---|
| Anmerkungen: |
Date Completed 08.02.2022 Date Revised 02.09.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.bjorl.2021.07.001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM33143654X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM33143654X | ||
| 003 | DE-627 | ||
| 005 | 20231225213447.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bjorl.2021.07.001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1104.xml |
| 035 | |a (DE-627)NLM33143654X | ||
| 035 | |a (NLM)34602350 | ||
| 035 | |a (PII)S1808-8694(21)00133-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tan, Mehmet |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The effect of genistein on cisplatin induced ototoxicity and oxidative stress |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.02.2022 | ||
| 500 | |a Date Revised 02.09.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier Editora Ltda. All rights reserved. | ||
| 520 | |a OBJECTIVE: Cisplatin is an antineoplastic agent used in adults and children for the treatment of various malignant diseases. It can cause irreversible ototoxicity. Genistein is a phytoestrogen. Genistein functions as an antioxidant and cell cycle inhibitor by inhibiting the DNA topoisomerase and tyrosine protein kinase enzymes. The protective effect of genistein in preventing cisplatin-induced ototoxicity and levels of the oxidative stress was investigated | ||
| 520 | |a METHODS: 32 Sprague Dawley rats were used in 4 groups (control, cisplatin, cisplatin + genistein, genistein). Otoacoustic emission measurements of the distortion product were performed on the 1st, 2nd and 5th days of the test protocol. Serum malondialdehyde, superoxide dismutase, catalase, glutathione peroxidase, total antioxidant status, total oxidant status and oxidative stress index measurements were made | ||
| 520 | |a RESULTS: The hearing of the cisplatin + genistein group was found to be better than that of the cisplatin group. While the malondialdehyde, total oxidant status and oxidative stress index parameters decreased significantly in the cisplatin + genistein group compared to the cisplatin group, superoxide dismutase increased significantly (p < 0.05) | ||
| 520 | |a CONCLUSION: Genistein showed positive effects against ototoxicity with its antioxidant effect | ||
| 520 | |a LEVEL OF EVIDENCE: Level 3 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cisplatin | |
| 650 | 4 | |a Genistein | |
| 650 | 4 | |a Ototoxicity | |
| 650 | 4 | |a Oxidative stress | |
| 650 | 7 | |a Antineoplastic Agents |2 NLM | |
| 650 | 7 | |a Antioxidants |2 NLM | |
| 650 | 7 | |a Genistein |2 NLM | |
| 650 | 7 | |a DH2M523P0H |2 NLM | |
| 650 | 7 | |a Cisplatin |2 NLM | |
| 650 | 7 | |a Q20Q21Q62J |2 NLM | |
| 700 | 1 | |a Toplu, Yüksel |e verfasserin |4 aut | |
| 700 | 1 | |a Varan, Emrah |e verfasserin |4 aut | |
| 700 | 1 | |a Sapmaz, Emrah |e verfasserin |4 aut | |
| 700 | 1 | |a Özhan, Onural |e verfasserin |4 aut | |
| 700 | 1 | |a Parlakpınar, Hakan |e verfasserin |4 aut | |
| 700 | 1 | |a Polat, Alaadin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Brazilian journal of otorhinolaryngology |d 2005 |g 88(2022), 1 vom: 10. Jan., Seite 105-111 |w (DE-627)NLM160421748 |x 1808-8686 |7 nnns |
| 773 | 1 | 8 | |g volume:88 |g year:2022 |g number:1 |g day:10 |g month:01 |g pages:105-111 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bjorl.2021.07.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 88 |j 2022 |e 1 |b 10 |c 01 |h 105-111 | ||